Abstract
In 2008, the US clot management device market, which comprises thrombectomy
devices, thrombolytic infusion catheters, neurovascular embolectomy devices,
and inferior vena cava filters (IVCFs), was valued at more than $550 million.
Over the next five years, this market will be driven by product innovations.
| 
View Cart
